Identification of 15 lncRNAs Signature for Predicting Survival Benefit of Advanced Melanoma Patients Treated with Anti-PD-1 Monotherapy

The blockade of programmed cell death protein 1 (PD-1) as monotherapy has been widely used in melanoma, but to identify melanoma patients with survival benefit from anti-PD-1 monotherapy is still a big challenge. There is an urgent need for prognostic signatures improving the prediction of immunothe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cells
Autores principales: Zhou, Jian-Guo, Liang, Bo, Liu, Jian-Guo, Jin, Su-Han, He, Si-Si, Frey, Benjamin, Gu, Ning, Fietkau, Rainer, Hecht, Markus, Ma, Hu, Gaipl, Udo S.
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8143567/
https://ncbi.nlm.nih.gov/pubmed/33922038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10050977
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares